Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AKBA compared with FLGT: revenue, margins and what each company keeps, and the suppliers and customers both name
AKBA
Akebia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
FLGT
Fulgent Genetics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AKBA
Akebia Therapeutics, Inc.
vs
FLGT
Fulgent Genetics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
AKBA
with
FLGT
No shared trading history for AKBA and FLGT.
No shared co-movers.
AKBA, solid
FLGT, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
AKBA
Akebia Therapeutics, Inc.
Change
0.70
· pre 0.70
· delayed
Mkt cap
$195.8M
Revenue
$49M
Q2 FY26
Revenue
$236M
FY25
FLGT
Fulgent Genetics, Inc.
Change
19.29
· pre 19.29
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$530.8M
Revenue
$85M
Q2 FY26
Revenue
$323M
FY25
vs
Compare
Pre-market
Nov 2 '26
delayed
AKBA
Akebia Therapeutics, Inc.
vs
FLGT
Fulgent Genetics, Inc.
0.70
pre 0.70
delayed
Price
19.29
pre 19.29
delayed
$195.8M
Mkt cap
$530.8M
Q2 FY26
$49M
Revenue
$85M
Q2 FY26
FY25
$236M
Revenue
$323M
FY25
Change
Change
AKBA
0.70
vs
FLGT
19.29
Pre-market
Nov 2 '26
delayed